AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 FEB 13 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell (CRXL) announced it has appointed Stef Heylen as its vice president of Development and Regulatory Affairs as of March 1, 2002.
Prior to joining Crucell, Heylen was VP Medical Affairs for Europe, Middle East, and Africa of Johnson & Johnson's division Janssen-Cilag. Since 1987 Heylen worked for the Janssen Research Foundation in various senior management positions related to clinical R&D, regulatory affairs and pharmacovigilance.
At Crucell, Heylen will handle all contacts with regulatory agencies, design, and implement Crucell's clinical trials and serve on the joint-steering committees with Crucell's current and future ...